Release Date: 13/02/12 11:42 Summary: Pelumat Prospect - A New Target Ready for Drill Testing Price Sensitive: Yes Download Document 4.59MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling